Expression of p150 in cervical neoplasia and its potential value in predicting survival

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cancer

• Publication date

  1998-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1PMID 9762939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The p53 tumour suppressor gene

  1998cited by this paper
• Prognostic factors

  1998cited by this paper
• Angiogenesis in cervical neoplasia: microvessel quantitation in precancerous lesions and invasive carcinomas with clinicopathological correlations.

  1997cited by this paper
• Cloning of a novel protein overexpressed in human mammary carcinoma.

  1997influential reference
• Analysis of proliferative activity using Ki-67 on cervical precancerous lesions and the relationship to p53 expression.

  1996cited by this paper
• Assessment of EGFR and TGF‐alpha expression in relationship to HPV status and KI‐67 distribution in cervical intraepithelial neoplasms

  1996cited by this paper
• Surgical Gynecologic Oncology

  1994cited by this paper
• Histopathologic predictors of the behavior of surgically treated stage IB squamous cell carcinoma of the cervix a gynecologic oncology group study

  1992cited by this paper
• Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis.

  1992cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• Squamous cell carcinoma of the uterine cervix--a review with emphasis on prognostic factors and unusual variants.

  1990cited by this paper
• The p53 proto-oncogene can act as a suppressor of transformation.

  1989cited by this paper
• New prognostic factors in squamous cell carcinoma of cervix uteri.

  1985cited by this paper

• EIF3B stabilizes PCNA by counteracting SYVN1-mediated ubiquitination to serve as a promotor in cholangiocarcinoma

  2024cites this paper
• eIf3a mediates malignant biological behaviors in colorectal cancer through the PI3K/AKT signaling pathway

  2024cites this paper
• Research progress of Eukaryon translation initiation factor 3 in Glioma

  2023cites this paper
• eIF3d: A driver of noncanonical cap–dependent translation of specific mRNAs and a trigger of biological/pathological processes

  2023cites this paper
• Translation initiation factor eIF3a regulates glucose metabolism and cell proliferation via promoting small GTPase Rheb synthesis and AMPK activation

  2022cites this paper
• eIF3a‐PPP2R5A‐mediated ATM/ATR dephosphorylation is essential for irinotecan‐induced DNA damage response

  2022cites this paper
• The Downregulation of eIF3a Contributes to Vemurafenib Resistance in Melanoma by Activating ERK via PPP2R1B

  2021cites this paper
• Knockdown of eIF3a attenuated cell growth in K1 human thyroid cancer cells

  2021cites this paper
• The effect of eIF3a on anthracycline-based chemotherapy resistance by regulating DSB DNA repair.

  2021cites this paper
• N6-methyladenine RNA modification and cancer.

  2020cites this paper
• eIF3i regulation of protein synthesis, cell proliferation, cell cycle progression, and tumorigenesis.

  2020cites this paper
• m6A ‘erasers’. Fat mass and obesity-associated protein (FTO) and alkB homolog 5 (ALKBH5) may function as m6A erasers (15,16). The last type of enzymes

  2020cites this paper
• eIF3a Regulation of NHEJ Repair Protein Synthesis and Cellular Response to Ionizing Radiation

  2020cites this paper
• Circular RNA screening from EIF3a in lung cancer

  2019cites this paper
• Upregulation of eukaryotic translation initiation factor 3 subunit a promotes cell survival in ameloblastoma.

  2019cites this paper
• Serum anti-EIF3A autoantibody as a potential diagnostic marker for hepatocellular carcinoma

  2019cites this paper
• eIF3a mediates HIF1α-dependent glycolytic metabolism in hepatocellular carcinoma cells through translational regulation.

  2019cites this paper
• eIF3: a factor for human health and disease

  2018cites this paper
• The function and clinical significance of eIF3 in cancer.

  2018cites this paper
• eIF3a: A new anticancer drug target in the eIF family.

  2018cites this paper
• EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma

  2018cites this paper
• MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

  2017cites this paper
• Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells

  2017cites this paper
• EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway

  2017cites this paper
• eIF3 Regulation of Protein Synthesis, Tumorigenesis, and Therapeutic Response.

  2017cites this paper
• The eIF3a Arg803Lys genetic polymorphism is associated with susceptibility to and chemoradiotherapy efficacy in cervical carcinoma

  2017cites this paper
• Eukaryotic translation initiation factors and cancer

  2017cites this paper
• Translational Control and mTOR in Cancer

  2017cites this paper
• eIF 3 C as a prognostic marker of colorectal cancer

  2017cites this paper
• Fluorofenidone attenuates bleomycin-induced pulmonary fibrosis by inhibiting eukaryotic translation initiation factor 3a (eIF3a) in rats.

  2016cites this paper
• Gr upSM Molecular Genetics of Cervical Precancerous Lesions : Implications to Prognostic Model Development

  2016cites this paper
• Role of eIF 3 a in regulating cisplatin sensitivity and nucleotide excision repair of nasopharyngeal carcinomas

  2016cites this paper
• Investigating the genetic basis of cisplatin-induced ototoxicity in adult South African patients

  2016cites this paper
• The oncogenic role of EIF3D is associated with increased cell cycle progression and motility in prostate cancer

  2015cites this paper
• EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma

  2015cites this paper
• eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation

  2015cites this paper
• Role of eIF3a expression in cellular sensitivity to ionizing radiation treatments by regulating synthesis of NHEJ repair proteins

  2015cites this paper
• The role of eIF3 and its individual subunits in cancer.

  2015cites this paper
• RNAI MEDIATED GENE SILENCING OF EIF3A: A POSSIBLE SOLUTION TO CONTROL BREAST CANCER

  2015cites this paper
• Knockdown of eIF3d inhibits cell proliferation through G2/M phase arrest in non-small cell lung cancer

  2015cites this paper
• The Prognostic Value of Altered eIF3a and Its Association with p27 in Non-Small Cell Lung Cancers

  2014cites this paper
• Penta-O-galloyl-β-D-glucose suppresses EGF-induced eIF3i expression through inhibition of the PI3K/AKT/mTOR pathway in prostate cancer cells.

  2014cites this paper
• The Translation Initiation Factor eIF3i Up-regulates Vascular Endothelial Growth Factor A, Accelerates Cell Proliferation, and Promotes Angiogenesis in Embryonic Development and Tumorigenesis*

  2014cites this paper
• eIF3a is over-expressed in urinary bladder cancer and influences its phenotype independent of translation initiation

  2014cites this paper
• [Correlation between eIF3a and HE4 expression and ovarian cancer].

  2014cites this paper
• Microarray Gene Expression Analysis of Tumorigenesis and Regional Lymph Node Metastasis in Laryngeal Squamous Cell Carcinoma

  2013cites this paper
• Spectrin Domain of Eukaryotic Initiation Factor 3a Is the Docking Site for Formation of the a:b:i:g Subcomplex*

  2013cites this paper
• The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients.

  2013cites this paper
• Eukaryotic translation initiation factors in cancer development and progression.

  2013cites this paper
• Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a.

  2013cites this paper
• Synthesis, Pharmacophores, and Mechanism Study of Pyridin‐2(1H)‐one Derivatives as Regulators of Translation Initiation Factor 3A

  2013cites this paper
• N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion

  2013cites this paper
• Mini Review: Relationship Between Platinum Induced Toxicities and Nucleotide Excision Repair (NER) Pathway Polymorphisms in Non-Small Cell Lung Cancer (NSCLC) Patients and Beyond

  2013cites this paper
• A meta-analysis of the relationship between lymphatic microvessel density and clinicopathological parameters in breast cancer.

  2013cites this paper
• The cholangiocyte marker, BD. 1, forms a stable complex with CLIP170 and shares an identity with eIF3a, a multifunctional subunit of the eIF3 initiation complex.

  2012cites this paper
• A Systematic Analysis of miRNA Transcriptome in Marek’s Disease Virus-Induced Lymphoma Reveals Novel and Differentially Expressed miRNAs

  2012cites this paper
• Overexpression of eIF3a in Squamous Cell Carcinoma of the Oral Cavity and Its Putative Relation to Chemotherapy Response

  2012cites this paper
• EIF3A (eukaryotic translation initiation factor 3, subunit A)

  2012cites this paper
• Translational control in cancer etiology.

  2012cites this paper
• The cancerous translation apparatus.

  2011cites this paper
• Role of eIF3a in regulating cisplatin sensitivity and nucleotide excision repair of nasopharyngeal carcinomas

  2011cites this paper
• Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair

  2011cites this paper
• Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.

  2011cites this paper
• The translational regulator eIF3a: the tricky eIF3 subunit!

  2010influential citation
• Translational control in cancer

  2010cites this paper
• Overexpression of p150, a part of the large subunit of the eukaryotic translation initiation factor 3, in colon cancer.

  2010cites this paper
• Profiling the potential biomarkers for cell differentiation of pancreatic cancer using iTRAQ and 2‐D LC‐MS/MS

  2009cites this paper
• The regulation of protein synthesis in cancer.

  2009cites this paper
• Role of eIF3a in regulating cell cycle progression.

  2009cites this paper
• RNA aptamers to translational components.

  2009cites this paper
• The let-7 microRNA interfaces extensively with the translation machinery to regulate cell differentiation

  2008cites this paper
• Individual Overexpression of Five Subunits of Human Translation Initiation Factor eIF3 Promotes Malignant Transformation of Immortal Fibroblast Cells*

  2007cites this paper
• Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development.

  2007cites this paper
• Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.

  2006cites this paper
• 4 - Role of Immunohistochemical Expression of p150 in Gastric Carcinoma: The Association with p53, Apoptosis, and Cell Proliferation

  2006cites this paper
• Cyclins and proliferation markers in early squamous cervical carcinoma.

  2004cites this paper
• Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth

  2004cites this paper
• p150 Overexpression in gastric carcinoma: The association with p53, apoptosis and cell proliferation

  2004cites this paper
• EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression.

  2003cites this paper
• EIF 3 p 170 , a Mediator of Mimosine Effect on Protein Synthesis and Cell Cycle Progression

  2003cites this paper
• Molecular interaction between human tumor marker protein p150, the largest subunit of eIF3, and intermediate filament protein K7

  2001cites this paper
• Identification of a 170-kDa protein over-expressed in lung cancers

  2001cites this paper
• Translational control of the proteome: Relevance to cancer

  2001cites this paper
• Two subcellular localizations of eIF3 p170 and its interaction with membrane-bound microfilaments: implications for alternative functions of p170.

  2001cites this paper
• Aminopeptidase A Expression in Cervical Neoplasia and Its Relationship to Neoplastic Transformation and Progression

  2000cites this paper
• p150 expression and its prognostic value in squamous‐cell carcinoma of the esophagus

  1999cites this paper